Status:
WITHDRAWN
ImmeDiate Versus EArLy Invasive Approach in Non-ST-Elevation Myocardial Infarction (IDEAL NSTEMI)
Lead Sponsor:
University of Leipzig
Collaborating Sponsors:
Stiftung Institut fuer Herzinfarktforschung
Conditions:
Non-ST-elevation Myocardial Infarction
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Of estimated 140,000 cases of acute myocardial infarction admitted to hospitals in Germany per year, approximately 50% present with Non-ST-elevation myocardial infarction (NSTEMI). The currently avail...
Eligibility Criteria
Inclusion
- NSTEMI with
- ischemic symptoms \>10 minutes within 24 h
- elevated troponin or creatine kinase above the upper limit of normal
- ST-segment depression or transient ST-segment elevation, T-wave inversion
- informed consent.
Exclusion
- Age \< 18 years
- Age \> 90 years
- persistent angina
- hemodynamic instability
- overt congestive heart failure
- life-threatening arrhythmias
- STEMI
- limited life-expectancy \< 6 months
- chronic oral anticoagulation
- fibrinolysis \< 48 hours
- PCI \< 14 days
- contraindication for treatment with glycoprotein IIb/IIIa inhibitors, heparin, aspirin and clopidogrel
- recent major trauma or surgery
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00954668
Start Date
January 1 2009
End Date
January 1 2009
Last Update
July 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Leipzig - Heart Center
Leipzig, Germany, 04289